EE98 A Budget Impact Analysis of Empagliflozin for Treatment of Patients with Type 2 Diabetes Mellitus at Increased Cardiovascular Risk in Tertiary Hospital, Riyadh, Saudi Arabia
Empagliflozin
Tertiary care
DOI:
10.1016/j.jval.2022.04.351
Publication Date:
2022-06-25T07:45:03Z
AUTHORS (3)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....